MDxHealth SA MDXH
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.60
- Day Range
- $0.51–0.61
- 52-Week Range
- $0.51–5.33
- Bid/Ask
- $0.57 / $0.58
- Shares Outstanding
- 51.36M
- Market Cap
- $29.07M
- Volume/Avg
- 1M / 574,908
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.26
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Value
- Total Number of Employees
- 364
- Website
- https://www.mdxhealth.com
Valuation
|
Metric
|
MDXH
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 0.26 |
Price/Cash Flow | — |
Price/Earnings
MDXH
Financial Strength
|
Metric
|
MDXH
|
|---|---|
Quick Ratio | 1.38 |
Current Ratio | 1.63 |
Interest Coverage | −1.79 |
Quick Ratio
MDXH
Profitability
|
Metric
|
MDXH
|
|---|---|
Return on Assets (Normalized) | −14.00% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −18.19% |
Return on Assets
MDXH
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| Rwynrcfbk | Crdsx | $176B | |||
| Danaher Corp
DHR
| Njtkrzsqtf | Bylk | $130B | |||
| IDEXX Laboratories Inc
IDXX
| Cfjzlzydch | Hxyk | $44B | |||
| Agilent Technologies Inc
A
| Prpqyqxgq | Ntvzq | $38B | |||
| Waters Corp
WAT
| Sstxchpg | Mmrj | $36B | |||
| IQVIA Holdings Inc
IQV
| Whysnthbw | Fynbtk | $31B | |||
| Illumina Inc
ILMN
| Jcbnvthhz | Nvmhc | $25B | |||
| Mettler-Toledo International Inc
MTD
| Sjvrjnrmwc | Pghkw | $23B | |||
| Quest Diagnostics Inc
DGX
| Ljnxjfn | Cdztgjz | $22B | |||
| Labcorp Holdings Inc
LH
| Dggfwvqjlb | Rzmsr | $22B |
United States